Ginkgo Bioworks Holdings (DNA) Total Non-Current Liabilities (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Total Non-Current Liabilities data on file, last reported at $568.2 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities fell 9.9% year-over-year to $568.2 million; the trailing twelve-month figure through Mar 2026 stood at $568.2 million (down 9.9% YoY), and the FY2025 full-year result was $588.2 million, down 8.78% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $568.2 million, down from $588.2 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $792.2 million in Q4 2022 and bottomed at $391.1 million in Q2 2022.
• The 5-year median for Total Non-Current Liabilities is $612.2 million (2025), against an average of $615.9 million.
• The widest annual swing landed in 2022, when Total Non-Current Liabilities soared 535.75%; it then plunged 31.36% in 2023.
• A 5-year view of Total Non-Current Liabilities shows it stood at $792.2 million in 2022, then tumbled by 31.36% to $543.8 million in 2023, then grew by 18.59% to $644.8 million in 2024, then fell by 8.78% to $588.2 million in 2025, then dropped by 3.41% to $568.2 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $568.2 million (Q1 2026), $588.2 million (Q4 2025), and $612.2 million (Q3 2025), per Business Quant data.

Peer Comparison